[ad_1]
The Food and Drug Administration (FDA) is expected to soon authorize emergency vaccination with the new drug in the United States. The vaccination campaign in the country is accelerating, but the goal is to secure additional supplies as soon as possible to anticipate possible mutations of new viruses during a pandemic that has claimed more than 500,000 lives. American lives.
After a full day of discussions, the FDA expert panel unanimously decided that the benefits of the new vaccine outweighed the risks for adults. If the FDA approves this decision, several million doses of J&J vaccines could be shipped to distribution points starting Monday.
This drug would be the third vaccine against COVID-19, certified for distribution in the United States.
“You need to do this,” said Jay Portnoy, a physician at Grace Children’s Hospital in Missouri. – We are involved in the race between mutations in the virus and the emergence of new variants that could further spread the disease, and [pastangų] for. “
To date, more than 47 million in the United States. People (14% of the population) have received at least one dose of the two-dose vaccines developed by Pfizer / BioNTech and Moderna, which were certified by the FDA in December. However, vaccination has stalled due to winter storms that disrupted limited supply and distribution of the preparations.
[ad_2]
